Amyotrophic Lateral Sclerosis

InnoCentive posts $1 million seeker challenge for biomarker discovery

Published in Law and Health Weekly, December 16th, 2006

InnoCentive announced that Prize4Life, Inc., a nonprofit organization founded to accelerate amyotrophic lateral sclerosis (ALS) disease research, has offered a $1 million incentive to help advance the treatment for the disease.

"This important challenge, identifying an ALS 'biomarker,' is an effort to identify a specific measurement for the disease that can aid in detection and response to therapy," said Jill A. Panetta, PhD, InnoCentive's chief scientific officer.

"Valid biomarkers will enhance our understanding of the pathological process in ALS and our ability to gauge treatment efficacy," said Robert H. Brown, MD, DPhil. Brown is a member of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry